Form 8-K - Current report:
SEC Accession No. 0001628280-24-037568
Filing Date
2024-08-16
Accepted
2024-08-16 16:25:28
Documents
16
Period of Report
2024-08-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhvn-20240816.htm   iXBRL 8-K 27782
2 EX-1.2 exhibit12-atm8xk81624.htm EX-1.2 28949
3 EX-5.1 exhibit51-atm8xk81624.htm EX-5.1 26540
7 image_0.jpg GRAPHIC 38443
  Complete submission text file 0001628280-24-037568.txt   271355

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20240816.xsd EX-101.SCH 1922
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20240816_lab.xml EX-101.LAB 21597
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20240816_pre.xml EX-101.PRE 12510
19 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20240816_htm.xml XML 2706
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Ltd. (Filer) CIK: 0001935979 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41477 | Film No.: 241217018
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)